From: In silico drug combination discovery for personalized cancer therapy
Cell line name | Site | Correlation coefficient | Best observed | Its predicted rank out of |
---|---|---|---|---|
 |  |  | drug combination | N drug combinations |
RPMI7951 | Skin | 0.893 | MK-4827.TEMOZOLOMIDE | 1 out of 88 |
HCT116 | Colon | 0.892 | ETOPOSIDE.MK-2206 | 7 out of 105 |
HT29 | Colon | 0.889 | AZD1775.MK-8776 | 2 out of 116 |
SW620 | Colon | 0.874 | BEZ-235.MK-8669 | 1 out of 108 |
PA1 | Ovarian | 0.868 | MK-2206.SUNITINIB | 5 out of 85 |
A2780 | Ovarian | 0.865 | DASATINIB.MK-5108 | 1 out of 112 |
MDAMB436 | Breast | 0.864 | MK-4827.TEMOZOLOMIDE | 1 out of 114 |
VCAP | Prostate | 0.856 | BEZ-235.MK-8669 | 1 out of 109 |
LOVO | Colon | 0.839 | MK-4827.TEMOZOLOMIDE | 1 out of 121 |
OV90 | Ovarian | 0.833 | AZD1775.MK-8776 | 1 out of 99 |
OCUBM | Breast | 0.831 | AZD1775.MK-8776 | 1 out of 62 |
NCIH1650 | Lung | 0.83 | DASATINIB.MK-2206 | 2 out of 91 |
A2058 | Skin | 0.829 | MK-4827.MK-8776 | 28 out of 119 |
SKMES1 | Lung | 0.825 | BEZ-235.MK-8669 | 1 out of 113 |
A427 | Lung | 0.807 | MK-8776.TEMOZOLOMIDE | 9 out of 105 |
SKOV3 | Ovarian | 0.798 | ERLOTINIB.MK-8669 | 3 out of 105 |
UACC62 | Skin | 0.797 | GEMCITABINE.MK-8776 | 5 out of 120 |
DLD1 | Colon | 0.79 | MK-2206.MK-8669 | 2 out of 116 |
ES2 | Ovarian | 0.789 | BEZ-235.MK-8669 | 1 out of 125 |
NCIH2122 | Lung | 0.766 | DEXAMETHASONE.MK-2206 | 8 out of 137 |
SKMEL30 | Skin | 0.709 | BEZ-235.MK-8669 | 1 out of 105 |
A375 | Skin | 0.691 | MK-4827.TEMOZOLOMIDE | 1 out of 103 |
RKO | Colon | 0.688 | GELDANAMYCIN.PD325901 | 20 out of 117 |
HT144 | Skin | 0.669 | MK-2206.SN-38 | 7 out of 124 |
NCIH520 | Lung | 0.643 | DASATINIB.TOPOTECAN | 20 out of 124 |
UWB1289 | Ovarian | 0.63 | BEZ-235.MK-8669 | 1 out of 125 |
MSTO | Lung | 0.628 | BEZ-235.MK-8669 | 1 out of 86 |
SW837 | Colon | 0.626 | BEZ-235.DASATINIB | 8 out of 110 |
OVCAR3 | Ovarian | 0.554 | AZD1775.SN-38 | 5 out of 93 |
T47D | Breast | 0.493 | DOXORUBICIN.MK-8669 | 1 out of 61 |
NCIH23 | Lung | 0.478 | L778123.MK-8669 | 2 out of 117 |